Structure Database (LMSD)
LM_ID | Common Name | Systematic Name | Main class | Sub class | Mass | Formula |
---|---|---|---|---|---|---|
LMSP0502AV04 | GalNAcalpha1-3GalNAcbeta1-3(Fucalpha1-2Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) | Neutral glycosphingolipids [SP05] | Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502] | 2025.11 | C94H168N4O42 | |
LMSP0504AP04 | GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) | Neutral glycosphingolipids [SP05] | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504] | 2025.11 | C94H168N4O42 | |
LMSP0504AX04 | Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) | Neutral glycosphingolipids [SP05] | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504] | 2025.11 | C94H168N4O42 | |
LMSP0505AQ04 | type II A antigen(d18:1/22:0) | GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) | Neutral glycosphingolipids [SP05] | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] | 2025.11 | C94H168N4O42 |
LMSP0505BH04 | GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) | Neutral glycosphingolipids [SP05] | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505] | 2025.11 | C94H168N4O42 |